American Kratom Association Thanks Governor DeWine And Ohio Board of Pharmacy For Taking A Thoughtful Approach On Kratom Regulation
Ohio BOP cancels Wednesday meeting on scheduling kratom
American Kratom Association (AKA) today commended Ohio Governor Mike DeWine and the Ohio Board of Pharmacy for their decision to take more time to carefully evaluate the proposed emergency scheduling of all kratom compounds.
“The Governor and Board of Pharmacy made the right call in pausing before taking sweeping action that would have harmed thousands of Ohio consumers who responsibly use kratom,” said Mac Haddow, senior fellow on public policy for the American Kratom Association. “We applaud their commitment to thoughtful consideration and welcome the opportunity to work together on a balanced policy.”
The AKA emphasized that its advocacy is aligned with the recent comments of HHS Secretary Kennedy and FDA Commissioner Makary, who have made clear that the real public health danger comes from 7-hydroxymitragynine (7-OH) — a manipulated designer opioid that does not occur in meaningful amounts in the natural kratom plant.
The Association reiterated its support for:
“Kratom consumers in Ohio and across the country want safe access to products they can trust,” Haddow said. “By focusing on removing dangerous synthetics while regulating natural kratom responsibly, Ohio can set a strong example for other states to follow.”
American Kratom Association expressed its commitment to working with Governor DeWine, the Ohio Board of Pharmacy, and Ohio lawmakers to implement a science-based regulatory framework that both protects consumers and ensures access to safe kratom products.
